Skip to main content
Terug
Watch Compare

Vicarious Surgical Inc.

Datakwaliteit: 83%
Ook genoteerd als RBOTW OTC
RBOT
OTC Manufacturing Measuring & Analyzing Instruments
€ 0,70
€ 0,00 (0,00%)
Marktkapitalisatie: 4,99 M
Prijs
€ 0,70
Marktkapitalisatie
4,99 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -45,21 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-270,15%
Onder sectorgemiddelde (-53,47%)
ROIC-127,56%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio4,75
Interest CoverageN/A

Waardering

PE (TTM)
-0,10
Boven sectorgemiddelde (-1,48)
P/B Ratio0,35
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -0,1 -1,5
P/B 0,4 1,6
ROE % -270,2 -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

1 analist
Hold
Huidig
€ 0,70
+614.3%
Koersdoel
€ 5,00
€ 5,00
€ 5,00
€ 5,00
Vooruitzicht
Forward K/W -0,32
Forward WPA -€ 2,17
Omzet Sch. 18,00 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 2,17
-€ 2,17 – -€ 2,17
 18,00 M 1
FY2026 -€ 4,07
-€ 4,07 – -€ 4,07
 0,0 1

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 1,37 -€ 1,65 -20,4%
Q32025 -€ 2,33 -€ 1,91 +17,9%
Q22025 -€ 2,50 -€ 2,23 +10,7%
Q12025 -€ 2,48 -€ 2,58 -4,0%

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -50,18 M
ROE -270,15% ROA -142,89%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -45,21 M
ROIC -127,56% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4,75
Interest Coverage N/A Asset Turnover N/A
Working Capital 11,90 M Tangible Book Value 14,09 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,10 Forward P/E N/A
P/B Ratio 0,35 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -906,53%
Market Cap 4,99 M Enterprise Value 1,82 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -6,35 OCF / Share -6,33
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 90,09%
SBC-Adj. FCF -55,18 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Revenue — — — — —
Net Income -50,18 M -63,22 M -71,07 M 5,16 M -161.178,0
EPS (Diluted) — — -0,49 0,04 —
Gross Profit — — — — —
Operating Income -50,03 M -66,56 M -80,67 M -80,08 M —
EBITDA — — — — —
R&D Expenses 33,60 M 40,16 M 47,58 M 43,90 M —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — 25.000,0 25.000,0 200.000,0 —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Total Assets 19,58 M 67,72 M 119,86 M 140,29 M 346,42 M
Total Liabilities 9,74 M 21,02 M 21,90 M 29,25 M 12,20 M
Shareholders' Equity 9,84 M 46,70 M 97,97 M 111,05 M 5,00 M
Total Debt — — 2,00 M 2,18 M —
Cash & Equivalents 2,57 M 9,74 M 52,82 M 116,21 M 1,10 M
Current Assets 11,58 M 51,70 M 100,95 M 120,40 M 1,23 M
Current Liabilities 3,90 M 7,67 M 7,28 M 8,39 M 126.220,0